Investing
U.S. drugmaker Mallinckrodt plans to file for bankruptcy protection
© Reuters.
(Reuters) – Mallinckrodt (OTC:) is planning to start bankruptcy proceedings in the coming days, the U.S. drugmaker said on Wednesday, as it struggles to make required settlement payments for lawsuits alleging that it helped fuel the U.S. opioid crisis.
The company has entered into a restructuring agreement, which will help it to reduce its total debt by about $1.9 billion.
One of the biggest manufacturers of opioid drugs, the company had emerged out of bankruptcy in 2022.
Read the full article here
-
Investing5 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Passive Income5 days ago
How to Create a Routine That Balances Rest and Business Success
-
Side Hustles6 days ago
Apple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Side Hustles3 days ago
A Macy’s Employee Made Accounting Errors Worth $132 Million
-
Investing2 days ago
Factbox-How Trump can overhaul US financial regulators when he takes office By Reuters
-
Passive Income2 days ago
5 Ways AI Can Accelerate Your Entrepreneurial Journey
-
Passive Income6 days ago
Customers Want More Than Just a Product — Here’s How to Keep Up
-
Side Hustles5 days ago
Gift the Power of Language Learning with This Limited-Time Price on Babbel